Abstract
It will be many years and decision‐making cycles before community leaders can draw firm conclusions on whether proceeds from litigation against opioid manufacturers, distributors and pharmacies prove to be a boon to substance use disorder (SUD) services. For the moment, observers have expressed cautious optimism that states are taking important steps to ensure no repeat of the empty promises that characterized the national tobacco settlement of the 1990s.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
